Percutaneous revascularization strategies in saphenous vein graft lesions: Long-term results

Revista Portuguesa de Cardiologia

Volumn 31, Issue 1, 2012, Pages 11-18

  Leal, Silvio ^a   Teles, Rui Campante ^a   Calé, Rita ^a   Sousa, Pedro Jerónimo ^a   Brito, João ^a   Raposo, Luis ^a   Gonçalves, Pedro Araujo ^a   Baptista, José ^a   Almeida, Manuel Sousa ^a   Silva, Aniceto ^a   Mendes, Miguel ^a  

^a HOSPITAL DE SANTA CRUZ   (Portugal)

Author keywords

Bare metal stents; Coronary artery bypass surgery; Drug eluting stents; Percutaneous coronary intervention; Saphenous vein graft

Indexed keywords

ARTICLE; BARE METAL STENT; DEATH; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SAPHENOUS VEIN GRAFT; SAPHENOUS VEIN GRAFT LESION; SURVIVAL; TARGET VESSEL FAILURE; VASCULAR DISEASE; VEIN GRAFT DISEASE;

EID: 84857110624     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2011.09.019     Document Type: Article

References (29)

1. Parang P, Arora R. Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol. 2009;25:57-62.
2. Brilakis E, Saeed B, Banerjee S. Use of drug-eluting stents in saphenous vein aortocoronary bypass graft lesions: a critical appraisal. J Interv Cardiol. 2008;21:151-7. (Pubitemid 351492481)
3. Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149-56. (Pubitemid 39576034)
4. Hiscock M, Oqueli E, Dick R. Percutaneous saphenous vein graft intervention - a review. Heart Lung Circ. 2007;16:551-5.
5. Keeley E, Velez C, O'Neill W, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38:659-65. (Pubitemid 32835732)
6. Sabik J, Blackstone E, Gillinov M, et al. Occurrence and risk factors for reintervention after coronary artery bypass grafting. Circulation. 2006;114:454-60.
7. Pucelikova T, Mehran R, Kirtane A, et al. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. Am J Cardiol. 2008;101:63-8. (Pubitemid 350297200)
8. Meliga E, García-García H, Kukreja N, et al. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization - long term follow-up in the drug-eluting stent era. Catheter Cardiovasc Interv. 2007;70:21-5. (Pubitemid 47039113)
9. Hoffmann R, Hamm C, Nienaber CA, et al. Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels. Coron Artery Dis. 2007; 18: 559-64. (Pubitemid 47556388)
10. Savage M, Douglas J, Fischman D, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo (SAVED) trial. Engl J Med. 1997;337:740-7. (Pubitemid 27417973)
11. Hanekamp CE, Koolen JJ, Den Heijer P, et al. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent Study. Catheter Cardiovasc Interv. 2003;60:452-7. (Pubitemid 37466749)
12. De Feyter PJ, van Suylen R, de Jaegere PP, et al. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol. 1993;21:1539-49. (Pubitemid 23170424)
13. Vermeersch P, Agostoni P. Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents? J Interv Cardiol. 2005;18:467-73. (Pubitemid 41726996)
14. Brilakis E, Berger P. Should bare-metal or drug eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot? Catheter Cardiovasc Interv. 2008;72:815-8.
15. Lee M, Shah A, Aragon J, et al. Drug-eluting stenting is superior to bare-metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv. 2005;66:507-11. (Pubitemid 41779016)
16. Ramana R, Ronan A, Cohoon K, et al. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. Catheter Cardiovasc Interv. 2008;71:886-93. (Pubitemid 351951305)
17. Brodie B, Wilson H, Stuckey T, et al. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention. Results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. JACC Cardiovasc Interv. 2009;2:1105-12.
18. Vermeersch P, Agostoni P, Verheye S, et al. Randomized double-blind comparison of sirolimus-eluting stent versus base-metal stent implantation in diseased saphenous vein grafts - The RRISC Trial. J Am Coll Cardiol. 2006;48:2423-31. (Pubitemid 44895571)
19. Vermeersch P, Agostoni P, Verheye S, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts - The DELAYED RRISC Trial. J Am Coll Cardiol. 2007;50:261-7. (Pubitemid 47039289)
20. Brilakis E, Lichtenwalter C, de Lemos J, et al. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions - The SOS Trial. J Am Coll Cardiol. 2009;53:919-28.
21. Chu W, Kuchulakanti P, Wang B, et al. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. J Interv Cardiol. 2006;19:121-5.
22. Okabe T, Lindsay J, Buch A, et al. Drug-eluting stents versus bare-metal stents for narrowing in saphenous vein grafts. Am J Cardiol. 2008;102:530-4.
23. Gioia G, Benassi A, Mohendra R, et al. Lack of clinical benefit with the use of a drug eluting stent compared to the use of a bare metal stent in saphenous vein grafts. Catheter Cardiovasc Interv. 2008;72:13-20. (Pubitemid 352008974)
24. Lozano I, García-Camarero T, Carrillo P, et al. Comparison of drug-eluting and bare-metal stents in saphenous vein grafts. Immediate and long-term results. Rev Esp Cardiol. 2009;62:39-47.
25. Lee M, Yang T, Kandzari D, et al. Comparison by meta-analysis of drug-eluting stents and bare-metal stents for saphenous vein graft intervention. Am J Cardiol. 2010;105:1076-82.
26. Sanchez-Recalde A, Jiménez Valero S, Moreno R, et al. Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis. Eurointervention. 2010;6:149-60.
27. Bairn DS. Percutaneous treatment of saphenous vein graft disease: the ongoing challenge. J Am Coll Cardiol. 2003;42:1370-2.
28. Goswami N, Gaffigan M, Berrio G, et al. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry. Catheter Cardiovasc Interv. 2010;75:93-100.
29. Bansal D, Muppidi R, Singla S, et al. Percutaneous intervention on the saphenous vein bypass grafts - long-term outcomes. Catheter Cardiovasc Interv. 2008;71:58-61. (Pubitemid 351158347)